BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15325261)

  • 21. Construction of FLAG tagging vectors for Candida albicans.
    Umeyama T; Nagai Y; Niimi M; Uehara Y
    Yeast; 2002 May; 19(7):611-8. PubMed ID: 11967831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans.
    Smriti ; Krishnamurthy SS; Prasad R
    FEMS Microbiol Lett; 1999 Apr; 173(2):475-81. PubMed ID: 10227177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation of candida glabrata ATP-binding cassette transporter Cdr1p regulates drug efflux activity and ATPase stability.
    Wada S; Tanabe K; Yamazaki A; Niimi M; Uehara Y; Niimi K; Lamping E; Cannon RD; Monk BC
    J Biol Chem; 2005 Jan; 280(1):94-103. PubMed ID: 15498768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
    Pasrija R; Prasad T; Prasad R
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
    Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
    J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans.
    Haque A; Rai V; Bahal BS; Shukla S; Lattif AA; Mukhopadhyay G; Prasad R
    Biochem Biophys Res Commun; 2007 Jan; 352(2):491-7. PubMed ID: 17126815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.
    Gauthier C; Weber S; Alarco AM; Alqawi O; Daoud R; Georges E; Raymond M
    Antimicrob Agents Chemother; 2003 May; 47(5):1543-54. PubMed ID: 12709320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulators of the Efflux Pump Cdr1p of Candida albicans: Mechanisms of Action and Chemical Features.
    Tran-Nguyen VK; Prasad R; Falson P; Boumendjel A
    Curr Med Chem; 2017; 24(30):3242-3253. PubMed ID: 28545374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conserved Asp327 of walker B motif in the N-terminal nucleotide binding domain (NBD-1) of Cdr1p of Candida albicans has acquired a new role in ATP hydrolysis.
    Rai V; Gaur M; Shukla S; Shukla S; Ambudkar SV; Komath SS; Prasad R
    Biochemistry; 2006 Dec; 45(49):14726-39. PubMed ID: 17144665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.
    Smriti ; Krishnamurthy S; Dixit BL; Gupta CM; Milewski S; Prasad R
    Yeast; 2002 Mar; 19(4):303-18. PubMed ID: 11870854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. W1038 near D-loop of NBD2 is a focal point for inter-domain communication in multidrug transporter Cdr1 of Candida albicans.
    Banerjee A; Shah AH; Redhu AK; Moreno A; Falson P; Prasad R
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):965-972. PubMed ID: 29410026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel catalytic mechanism for ATP hydrolysis employed by the N-terminal nucleotide-binding domain of Cdr1p, a multidrug ABC transporter of Candida albicans.
    Rai V; Gaur M; Kumar A; Shukla S; Komath SS; Prasad R
    Biochim Biophys Acta; 2008 Oct; 1778(10):2143-53. PubMed ID: 18498759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alanine scanning of transmembrane helix 11 of Cdr1p ABC antifungal efflux pump of Candida albicans: identification of amino acid residues critical for drug efflux.
    Saini P; Prasad T; Gaur NA; Shukla S; Jha S; Komath SS; Khan LA; Haq QM; Prasad R
    J Antimicrob Chemother; 2005 Jul; 56(1):77-86. PubMed ID: 15937063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alanine scanning of all cysteines and construction of a functional cysteine-less Cdr1p, a multidrug ABC transporter of Candida albicans.
    Prasad R; Shah AH; Sanwal H; Kapoor K
    Biochem Biophys Res Commun; 2012 Jan; 417(1):508-13. PubMed ID: 22166216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blocking and dislocation of Candida albicans Cdr1p transporter by styrylquinolines.
    Szczepaniak J; Cieślik W; Romanowicz A; Musioł R; Krasowska A
    Int J Antimicrob Agents; 2017 Aug; 50(2):171-176. PubMed ID: 28602766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into pleiotropic drug resistance ATP-binding cassette pump drug transport through mutagenesis of Cdr1p transmembrane domains.
    Rawal MK; Khan MF; Kapoor K; Goyal N; Sen S; Saxena AK; Lynn AM; Tyndall JD; Monk BC; Cannon RD; Komath SS; Prasad R
    J Biol Chem; 2013 Aug; 288(34):24480-93. PubMed ID: 23824183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newly identified motifs in Candida albicans Cdr1 protein nucleotide binding domains are pleiotropic drug resistance subfamily-specific and functionally asymmetric.
    Rawal MK; Banerjee A; Shah AH; Khan MF; Sen S; Saxena AK; Monk BC; Cannon RD; Bhatnagar R; Mondal AK; Prasad R
    Sci Rep; 2016 Jun; 6():27132. PubMed ID: 27251950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and GSH modulation of MRP1-mediated transport.
    Rothnie A; Conseil G; Lau AY; Deeley RG; Cole SP
    Mol Pharmacol; 2008 Dec; 74(6):1630-40. PubMed ID: 18768387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.